Exploring Unintended Consequences from the Prospective Payment System Transitional Drug Add-On Payment Adjustment to Refine Program Enhancement Strategies.
作者信息
Molony Donald Andrew, Waguespack Dia Rose
机构信息
Department of Medicine, University of Texas McGovern Medical School, Houston, Texas.
出版信息
Clin J Am Soc Nephrol. 2025 Jan 10;20(2):154-5. doi: 10.2215/CJN.0000000649.
Abstract
摘要
相似文献
1
Exploring Unintended Consequences from the Prospective Payment System Transitional Drug Add-On Payment Adjustment to Refine Program Enhancement Strategies.探索预期支付系统过渡性药物附加支付调整产生的意外后果，以完善项目增强策略。
Clin J Am Soc Nephrol. 2025 Jan 10;20(2):154-5. doi: 10.2215/CJN.0000000649.
2
An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes.评估经济激励措施在改变医疗保健专业人员行为和患者结局方面有效性的综述概述。
Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD009255. doi: 10.1002/14651858.CD009255.
3
Pharmaceutical policies: effects of cap and co-payment on rational drug use.药品政策：封顶支付和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD007017. doi: 10.1002/14651858.CD007017.
4
Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为遏制新冠疫情而采取的措施所产生的意外后果：一项范围综述。
Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD015397. doi: 10.1002/14651858.CD015397.pub2.
5
Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.
Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e473822. doi: 10.1200/EDBK-25-473822. Epub 2025 Jun 17.
6
Incentives in immunisation campaigns in low- and middle-income countries: a scoping review mapping evidence on effectiveness and unintended consequences.低收入和中等收入国家免疫接种运动中的激励措施：一项关于有效性和意外后果证据的范围界定综述
BMJ Glob Health. 2025 Jun 30;10(6):e019662. doi: 10.1136/bmjgh-2025-019662.
7
The effect of financial incentives on the quality of health care provided by primary care physicians.经济激励措施对初级保健医生所提供医疗服务质量的影响。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD008451. doi: 10.1002/14651858.CD008451.pub2.
8
Payment methods for outpatient care facilities.门诊护理机构的支付方式。
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD011153. doi: 10.1002/14651858.CD011153.pub2.
9
Value-Based Payment in Medicare: Progress, Challenges, and Future Directions.
J Health Polit Policy Law. 2025 Jun 20. doi: 10.1215/03616878-11995200.
10
Experiences and Interest in Value-Based Payment Arrangements for Medical Products Among Medicaid Agencies: An Exploratory Analysis.医疗产品基于价值的支付安排在医疗补助机构中的经验和兴趣：探索性分析。
Milbank Q. 2024 Sep;102(3):713-731. doi: 10.1111/1468-0009.12703. Epub 2024 Jun 7.
本文引用的文献
1
Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation.拟钙剂纳入终末期肾病综合治疗方案：过渡性药物附加支付调整指定结束后依替卡肽使用及甲状旁腺激素控制情况的变化
Clin J Am Soc Nephrol. 2024 Oct 8;20(2):218-28. doi: 10.2215/CJN.0000000583.
2
Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.继发性甲状旁腺功能亢进和高磷血症对慢性肾脏病进展及心血管事件的独立影响：来自NEFRONA队列的分析
Nephrol Dial Transplant. 2022 Mar 25;37(4):663-672. doi: 10.1093/ndt/gfab184.
3
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常（CKD-MBD）诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.
4
Calcimimetics and Bundled Reimbursement.钙敏感受体激动剂和捆绑式报销。
Am J Kidney Dis. 2019 Mar;73(3):385-390. doi: 10.1053/j.ajkd.2018.11.007. Epub 2019 Jan 3.
5
The ESRD Quality Incentive Program-Can We Bridge the Chasm?终末期肾病质量激励计划——我们能弥合差距吗？
J Am Soc Nephrol. 2017 Jun;28(6):1697-1706. doi: 10.1681/ASN.2016101079. Epub 2017 Mar 15.
6
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.依特立钙对比西那卡塞对继发性甲状旁腺功能亢进行血液透析患者甲状旁腺激素的影响：一项随机临床试验。
JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468.
7
Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.医疗保险计划；终末期肾病前瞻性支付系统及质量激励计划。最终规则。
Fed Regist. 2015 Nov 6;80(215):68967-9077.
8
A history of and a vision for CMS quality measurement programs.医疗保险与医疗补助服务中心（CMS）质量测量项目的历史与愿景。
Jt Comm J Qual Patient Saf. 2012 Oct;38(10):465-70. doi: 10.1016/s1553-7250(12)38062-8.
9
The 2011 ESRD prospective payment system: welcome to the bundle.2011年终末期肾病前瞻性支付系统：欢迎加入捆绑支付。
Am J Kidney Dis. 2011 Apr;57(4):539-41. doi: 10.1053/j.ajkd.2011.01.007. Epub 2011 Feb 18.
Zotero 插件